-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $510 Price Target

Benzinga·02/18/2026 17:00:42
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $510 price target.